Overview

Gender

male

Investor Type

Angel

Thomas is a former assistant professor in clinical hematology/oncology from Hopital Mondor in Paris, with a special focus on lymphoma epigenetics and a former member of Ari Melnick’s lab in Weill Cornell, New York.

In 2016, Thomas co-founded Owkin with Gilles Wainrib, a pioneer in the field of machine learning in biology.

Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Its focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer.

Owkin uses AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes.

Using federated learning, a pioneering collaborative AI framework, Owkin enables medical and biopharma partners to unlock valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data.